Recombinant Drug Development, Regulation, and CommercializationAn Indian Industry Perspective

被引:0
|
作者
Niharika Sahoo
Padmavati Manchikanti
机构
[1] Indian Institute of Technology Kharagpur,Rajiv Gandhi School of Intellectual Property Law
来源
BioDrugs | 2011年 / 25卷
关键词
Streptokinase; European Medicine Agency; Regulatory Approval; Marketing Authorization; Good Manufacturing Practice;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:105 / 113
页数:8
相关论文
共 50 条
  • [21] REGULATION - AN INDUSTRY PERSPECTIVE
    JASS, HE
    COSMETICS & TOILETRIES, 1985, 100 (02): : 27 - &
  • [22] Cloud-based data systems in drug regulation: an industry perspective
    Robertson, Andrew S.
    Malone, Hilary
    Bisordi, Fabio
    Fitton, Helen
    Garner, Carlos
    Holdsworth, Stacy
    Honig, Peter
    Hukkelhoven, Mathias
    Kowalski, Robert
    Milligan, Sandra
    O'Dowd, Liza
    Roberts, Khyati
    Rohrer, Michelle
    Stewart, Jerry
    Taisey, Mark
    Thakkar, Roopal
    Van Baelen, Karin
    Wegner, Max
    NATURE REVIEWS DRUG DISCOVERY, 2020, 19 (06) : 365 - 366
  • [23] Development of Environmental Regulation in Energy Industry of China: A Comparative Perspective
    Huang, Linjun
    ADVANCES IN ENERGY SCIENCE AND TECHNOLOGY, PTS 1-4, 2013, 291-294 : 1271 - 1274
  • [24] CLINICAL RESEARCH AND DRUG DEVELOPMENT OF ANTIVIRALS IN HIV - AN INDUSTRY PERSPECTIVE
    CARTER, SK
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 : S107 - S113
  • [25] Models and approaches to early neuropharmacologic drug development: An industry perspective
    Tallman, J
    BIOLOGICAL PSYCHIATRY, 1998, 43 : 82S - 82S
  • [26] Role of population pharmacokinetics in drug development - A pharmaceutical industry perspective
    Samara, E
    Granneman, R
    CLINICAL PHARMACOKINETICS, 1997, 32 (04) : 294 - 312
  • [27] Drug development: successes, problems and pitfalls-the industry perspective
    Wein, Wolfgang
    ESMO OPEN, 2016, 1 (01)
  • [28] An industry perspective on tiered approach to the investigation of metabolites in drug development
    Huskey, Su-Er W.
    Li, Wenkui
    Mangold, James B.
    Flarakos, Jimmy
    BIOANALYSIS, 2014, 6 (05) : 617 - 628
  • [29] Industry Perspective - What does Industry Need to Accelerate Drug Product and Process Development?
    Chatterjee, Bikash
    Steiner, Richard
    Kaul, Goldi
    PHARMACEUTICAL RESEARCH, 2024, 41 (01) : 7 - 11
  • [30] Industry Perspective – What does Industry Need to Accelerate Drug Product and Process Development?
    Bikash Chatterjee
    Richard Steiner
    Goldi Kaul
    Pharmaceutical Research, 2024, 41 : 7 - 11